NIGHTSTAR THERAPEUTICS

📍 London, United Kingdom🗓 Founded 2013👥 14 employees💰 Last funded 2015
Biotechnology🌐 nightstartx.com
Website LinkedIn
Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in NIGHTSTAR THERAPEUTICS?
NIGHTSTAR THERAPEUTICS has 2 investors on record on gritt.io, including 2 early-stage backers.
When did NIGHTSTAR THERAPEUTICS last raise funding?
The most recent investment in NIGHTSTAR THERAPEUTICS recorded on gritt.io was in 2015.
When was NIGHTSTAR THERAPEUTICS founded?
NIGHTSTAR THERAPEUTICS was founded in 2013.
What industry is NIGHTSTAR THERAPEUTICS in?
NIGHTSTAR THERAPEUTICS operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is NIGHTSTAR THERAPEUTICS based?
NIGHTSTAR THERAPEUTICS is headquartered in London, United Kingdom.